Potter, Gail E.
Callier, Viviane
Shrestha, Biraj
Joshi, Sudhaunshu
Dwivedi, Ankit
Silva, Joana C.
Laurens, Matthew B.
Follmann, Dean A.
Deye, Gregory A.
Clinical trials referenced in this document:
Documents that mention this clinical trial
Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial
https://doi.org/10.1016/s0140-6736(15)60721-8
Can incorporating genotyping data into efficacy estimators improve efficiency of early phase malaria vaccine trials?
https://doi.org/10.1186/s12936-023-04802-0
Efficacy and Safety of the RTS,S/AS01 Malaria Vaccine during 18 Months after Vaccination: A Phase 3 Randomized, Controlled Trial in Children and Young Infants at 11 African Sites
https://doi.org/10.1371/journal.pmed.1001685
Documents that mention this clinical trial
Can incorporating genotyping data into efficacy estimators improve efficiency of early phase malaria vaccine trials?
https://doi.org/10.1186/s12936-023-04802-0
Documents that mention this clinical trial
Can incorporating genotyping data into efficacy estimators improve efficiency of early phase malaria vaccine trials?
https://doi.org/10.1186/s12936-023-04802-0
Strategies for Understanding and Reducing the Plasmodium vivax and Plasmodium ovale Hypnozoite Reservoir in Papua New Guinean Children: A Randomised Placebo-Controlled Trial and Mathematical Model
https://doi.org/10.1371/journal.pmed.1001891
Funding for this research was provided by:
National Institutes of Health (HHSN261201500003I, U01AI112367)
National Institutes of Health,United States (R01 AI141900, R01 AI141900)
National Institutes of Health
Article History
Received: 19 September 2023
Accepted: 22 November 2023
First Online: 19 December 2023
Declarations
:
: Not applicable.
: Not applicable.
: The authors declare no competing interests.